Cargando…
Clinical characteristics and therapeutic response of differentiated thyroid carcinoma with obesity and diabetes
BACKGROUND: The effects of obesity and diabetes on the clinical outcomes of differentiated thyroid cancer (DTC) remain unclear. OBJECTIVES: To explore the association between obesity and diabetes with pathological features and therapeutic response of DTC. METHODS: Patients were categorized based on...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10631042/ https://www.ncbi.nlm.nih.gov/pubmed/37940857 http://dx.doi.org/10.1186/s12885-023-11591-x |
_version_ | 1785132284317270016 |
---|---|
author | Wang, Xuan Yu, Yang Ji, Yanhui Ma, Ziyu Tan, Jian Jia, Qiang Li, Ning Zheng, Wei |
author_facet | Wang, Xuan Yu, Yang Ji, Yanhui Ma, Ziyu Tan, Jian Jia, Qiang Li, Ning Zheng, Wei |
author_sort | Wang, Xuan |
collection | PubMed |
description | BACKGROUND: The effects of obesity and diabetes on the clinical outcomes of differentiated thyroid cancer (DTC) remain unclear. OBJECTIVES: To explore the association between obesity and diabetes with pathological features and therapeutic response of DTC. METHODS: Patients were categorized based on body mass index (BMI) and glycemic status. Compare the correlation between BMI and glycemic status with pathological features and therapeutic response of DTC. To analyze the independent risk factors for the aggressiveness of DTC. RESULTS: The proportion of patients with bilateral tumors was higher in the overweight, obese and diabetes group (P = 0.001, 0.045). The overweight group demonstrated a higher TNM stage (P = 0.004), while the T and TNM stages were higher in the diabetes group (P = 0.032, 0.000). The probability of distant metastasis increases by 37.4% for each unit of BMI increase (odds ratio (OR) = 1.374, CI 95% 1.061–1.778, P < 0.05). The BMI of Biochemical Incomplete Response (BIR) is significantly higher than that of Excellent Response (ER) (P = 0.015), the fasting plasma glucose (FPG) of Structural Incomplete (SIR) was significantly higher than that of ER and BIR (P = 0.030, 0.014). CONCLUSION: Obesity and diabetes have effect on DTC aggressiveness. BMI and FPG have correlation with the therapeutic response of DTC patients. |
format | Online Article Text |
id | pubmed-10631042 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-106310422023-11-07 Clinical characteristics and therapeutic response of differentiated thyroid carcinoma with obesity and diabetes Wang, Xuan Yu, Yang Ji, Yanhui Ma, Ziyu Tan, Jian Jia, Qiang Li, Ning Zheng, Wei BMC Cancer Research BACKGROUND: The effects of obesity and diabetes on the clinical outcomes of differentiated thyroid cancer (DTC) remain unclear. OBJECTIVES: To explore the association between obesity and diabetes with pathological features and therapeutic response of DTC. METHODS: Patients were categorized based on body mass index (BMI) and glycemic status. Compare the correlation between BMI and glycemic status with pathological features and therapeutic response of DTC. To analyze the independent risk factors for the aggressiveness of DTC. RESULTS: The proportion of patients with bilateral tumors was higher in the overweight, obese and diabetes group (P = 0.001, 0.045). The overweight group demonstrated a higher TNM stage (P = 0.004), while the T and TNM stages were higher in the diabetes group (P = 0.032, 0.000). The probability of distant metastasis increases by 37.4% for each unit of BMI increase (odds ratio (OR) = 1.374, CI 95% 1.061–1.778, P < 0.05). The BMI of Biochemical Incomplete Response (BIR) is significantly higher than that of Excellent Response (ER) (P = 0.015), the fasting plasma glucose (FPG) of Structural Incomplete (SIR) was significantly higher than that of ER and BIR (P = 0.030, 0.014). CONCLUSION: Obesity and diabetes have effect on DTC aggressiveness. BMI and FPG have correlation with the therapeutic response of DTC patients. BioMed Central 2023-11-08 /pmc/articles/PMC10631042/ /pubmed/37940857 http://dx.doi.org/10.1186/s12885-023-11591-x Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Wang, Xuan Yu, Yang Ji, Yanhui Ma, Ziyu Tan, Jian Jia, Qiang Li, Ning Zheng, Wei Clinical characteristics and therapeutic response of differentiated thyroid carcinoma with obesity and diabetes |
title | Clinical characteristics and therapeutic response of differentiated thyroid carcinoma with obesity and diabetes |
title_full | Clinical characteristics and therapeutic response of differentiated thyroid carcinoma with obesity and diabetes |
title_fullStr | Clinical characteristics and therapeutic response of differentiated thyroid carcinoma with obesity and diabetes |
title_full_unstemmed | Clinical characteristics and therapeutic response of differentiated thyroid carcinoma with obesity and diabetes |
title_short | Clinical characteristics and therapeutic response of differentiated thyroid carcinoma with obesity and diabetes |
title_sort | clinical characteristics and therapeutic response of differentiated thyroid carcinoma with obesity and diabetes |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10631042/ https://www.ncbi.nlm.nih.gov/pubmed/37940857 http://dx.doi.org/10.1186/s12885-023-11591-x |
work_keys_str_mv | AT wangxuan clinicalcharacteristicsandtherapeuticresponseofdifferentiatedthyroidcarcinomawithobesityanddiabetes AT yuyang clinicalcharacteristicsandtherapeuticresponseofdifferentiatedthyroidcarcinomawithobesityanddiabetes AT jiyanhui clinicalcharacteristicsandtherapeuticresponseofdifferentiatedthyroidcarcinomawithobesityanddiabetes AT maziyu clinicalcharacteristicsandtherapeuticresponseofdifferentiatedthyroidcarcinomawithobesityanddiabetes AT tanjian clinicalcharacteristicsandtherapeuticresponseofdifferentiatedthyroidcarcinomawithobesityanddiabetes AT jiaqiang clinicalcharacteristicsandtherapeuticresponseofdifferentiatedthyroidcarcinomawithobesityanddiabetes AT lining clinicalcharacteristicsandtherapeuticresponseofdifferentiatedthyroidcarcinomawithobesityanddiabetes AT zhengwei clinicalcharacteristicsandtherapeuticresponseofdifferentiatedthyroidcarcinomawithobesityanddiabetes |